MX9604786A - Composicion farmaceutica. - Google Patents

Composicion farmaceutica.

Info

Publication number
MX9604786A
MX9604786A MX9604786A MX9604786A MX9604786A MX 9604786 A MX9604786 A MX 9604786A MX 9604786 A MX9604786 A MX 9604786A MX 9604786 A MX9604786 A MX 9604786A MX 9604786 A MX9604786 A MX 9604786A
Authority
MX
Mexico
Prior art keywords
lens
pharmaceutical composition
increase
antigen
microorganism
Prior art date
Application number
MX9604786A
Other languages
English (en)
Other versions
MXPA96004786A (es
Inventor
Eri Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of MX9604786A publication Critical patent/MX9604786A/es
Publication of MXPA96004786A publication Critical patent/MXPA96004786A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica que comprende, como un ingrediente activo, un antígeno de lente que induce una respuesta inmunologica contra daños a las células de la lente, o un microorganismo capaz de expresar un antígeno de lente que induce una respuesta inmunologica contra daños a las células de la lente. La composicion farmacéutica de la presente invencion que contiene, como un ingrediente activo, un antígeno de lente o un microorganismo capaz de expresar dicho antígeno, muestra efectos inhibidores notablemente superiores, sobre el aumento en el título de anticuerpos de proteína anti-lente. Por consiguiente, trata o previene, muy probablemente, las cataratas en forma efectiva y retrasa el inicio de las cataratas. Así pues, la composicion de extremadamente util para pacientes con cataratas y pacientes de cataratas en reserva.
MXPA/A/1996/004786A 1995-10-13 1996-10-11 Composicion farmaceutica MXPA96004786A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP291993/1995 1995-10-13
JP29199395 1995-10-13
JP7-291993 1995-10-13

Publications (2)

Publication Number Publication Date
MX9604786A true MX9604786A (es) 1998-05-31
MXPA96004786A MXPA96004786A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
CA2187482A1 (en) 1997-04-14
CN1151894A (zh) 1997-06-18
EP0770398A2 (en) 1997-05-02
EP0770398A3 (en) 1997-07-09
US5871739A (en) 1999-02-16
AU6814496A (en) 1997-04-17
NO964309D0 (no) 1996-10-10
BR9605131A (pt) 1998-07-07
HUP9602822A2 (en) 1997-08-28
HU9602822D0 (en) 1996-11-28
NO964309L (no) 1997-04-14
PL316488A1 (en) 1997-04-14
KR970020117A (es) 1997-05-28
ZA968616B (en) 1997-05-13

Similar Documents

Publication Publication Date Title
FI961621A (fi) Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
NO973250D0 (no) Preparater for avlevering av antigener
MX9707431A (es) Inhibidores de la proteina cinasa c.
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
YU49315B (sh) Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
CA2137203A1 (en) Protein kinase c inhibitors
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
AR012376A1 (es) Formulacion de gel para la aplicacion topica
DE69830492D1 (de) Antikörper als ARZNEIMITTEL GEGEN LYMPHOCYTISCHE TUMORE (AUSSCHLIESSLICH MYELOME)
NZ500589A (en) Leptin (ob protein) and active fractions and fragments thereof as inhibitors of tumor cell proliferation
GEP20084346B (en) Protein kinase c inhibitors
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
ZA943920B (en) Pharmaceutical compositions
AU1041397A (en) Antigenic protein originating in malassezia
MX9604786A (es) Composicion farmaceutica.
AU644621B2 (en) Pharmaceutical composition for treating or preventing retroviral infections
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
IE871769L (en) Fluorooxirane carboxylates
SE9502219D0 (sv) Novel medical use
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
NO305750B1 (no) Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene
DE59608611D1 (de) Topische aciclovir-zubereitung
NO302360B1 (no) NG-monometyl-L-argininhydrokloridderivater